Cargando…
siRNA knockdown validation 101: Incorporating negative controls in antibody research
More antibody validation protocols would identify non-specific reagents – a major source of irreproducible research – with the inclusion of negative controls. This article presents an overview of one such method: siRNA knockdown. The authors outline a general protocol, the knockdown mechanism, and t...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792204/ https://www.ncbi.nlm.nih.gov/pubmed/26998240 http://dx.doi.org/10.12688/f1000research.8159.1 |
_version_ | 1782421207504650240 |
---|---|
author | Olds, Will Li, Jason |
author_facet | Olds, Will Li, Jason |
author_sort | Olds, Will |
collection | PubMed |
description | More antibody validation protocols would identify non-specific reagents – a major source of irreproducible research – with the inclusion of negative controls. This article presents an overview of one such method: siRNA knockdown. The authors outline a general protocol, the knockdown mechanism, and tips for evaluating knockdown experiments. |
format | Online Article Text |
id | pubmed-4792204 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | F1000Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-47922042016-03-18 siRNA knockdown validation 101: Incorporating negative controls in antibody research Olds, Will Li, Jason F1000Res Opinion Article More antibody validation protocols would identify non-specific reagents – a major source of irreproducible research – with the inclusion of negative controls. This article presents an overview of one such method: siRNA knockdown. The authors outline a general protocol, the knockdown mechanism, and tips for evaluating knockdown experiments. F1000Research 2016-03-09 /pmc/articles/PMC4792204/ /pubmed/26998240 http://dx.doi.org/10.12688/f1000research.8159.1 Text en Copyright: © 2016 Olds W and Li J http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Opinion Article Olds, Will Li, Jason siRNA knockdown validation 101: Incorporating negative controls in antibody research |
title | siRNA knockdown validation 101: Incorporating negative controls in antibody research |
title_full | siRNA knockdown validation 101: Incorporating negative controls in antibody research |
title_fullStr | siRNA knockdown validation 101: Incorporating negative controls in antibody research |
title_full_unstemmed | siRNA knockdown validation 101: Incorporating negative controls in antibody research |
title_short | siRNA knockdown validation 101: Incorporating negative controls in antibody research |
title_sort | sirna knockdown validation 101: incorporating negative controls in antibody research |
topic | Opinion Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792204/ https://www.ncbi.nlm.nih.gov/pubmed/26998240 http://dx.doi.org/10.12688/f1000research.8159.1 |
work_keys_str_mv | AT oldswill sirnaknockdownvalidation101incorporatingnegativecontrolsinantibodyresearch AT lijason sirnaknockdownvalidation101incorporatingnegativecontrolsinantibodyresearch |